Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis.
Caroline RuetschDarin T OkudaFanny RocherSophie Tartare-DeckertMarcel DeckertChristine Lebrun-FrénayPublished in: Neurology and therapy (2022)
-RM treatments used at therapeutic concentrations for patients with MS and should raise the question of increased dermatologic surveillance.